→
UnitedHealth Group Inc has a market capitalization of $372.09B and is currently trading at $408.45, reflecting a change of +$3.17 (+0.78%) from the previous close of $405.28. The company's P/E ratio stands at 30.87, while its revenue growth year-over-year is 11.81%, despite an EPS growth decline of 14.70%. The stock has a 52-week range of $235 to $416, with a current dividend yield of 2.13%.
Investors may consider monitoring UnitedHealth's earnings performance and growth metrics to inform their decisions.
Some investors point to UnitedHealth's revenue growth of 11.81% year-over-year as a strong indication of its market position in the healthcare industry. Additionally, a dividend yield of 2.13% may attract income-focused investors, particularly in a low-interest-rate environment.
On the other hand, the company faces challenges with a significant EPS decline of 14.70%, which may raise concerns about profitability. The P/E ratio of 30.87 could suggest that the stock is relatively expensive compared to its earnings, potentially deterring value-focused investors.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
UnitedHealth Group Inc has a market capitalization of $372.09B and is currently trading at $408.45, reflecting a change of +$3.17 (+0.78%) from the previous close of $405.28. The company's P/E ratio stands at 30.87, while its revenue growth year-over-year is 11.81%, despite an EPS growth decline of 14.70%. The stock has a 52-week range of $235 to $416, with a current dividend yield of 2.13%.
On the other hand, the company faces challenges with a significant EPS decline of 14.70%, which may raise concerns about profitability. The P/E ratio of 30.87 could suggest that the stock is relatively expensive compared to its earnings, potentially deterring value-focused investors.
Some investors point to UnitedHealth's revenue growth of 11.81% year-over-year as a strong indication of its market position in the healthcare industry. Additionally, a dividend yield of 2.13% may attract income-focused investors, particularly in a low-interest-rate environment.
Some investors point to UnitedHealth's revenue growth of 11.81% year-over-year as a strong indication of its market position in the healthcare industry. Additionally, a dividend yield of 2.13% may attract income-focused investors, particularly in a low-interest-rate environment. On the other hand, the company faces challenges with a significant EPS decline of 14.70%, which may raise concerns about profitability. The P/E ratio of 30.87 could suggest that the stock is relatively expensive compared to its earnings, potentially deterring value-focused investors.
UnitedHealth Group Inc has a market capitalization of $372.09B and is currently trading at $408.45, reflecting a change of +$3.17 (+0.78%) from the previous close of $405.28. The company's P/E ratio stands at 30.87, while its revenue growth year-over-year is 11.81%, despite an EPS growth decline of 14.70%. The stock has a 52-week range of $235 to $416, with a current dividend yield of 2.13%.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.
Helm Terminal offers free AI-powered stock analysis for UNH at helmterminal.dev/analyze/UNH, updated continuously during US market hours. No signup required.